Skip to main content
. 2018 Jul 9;9:1563. doi: 10.3389/fimmu.2018.01563

Figure 1.

Figure 1

Miltefosine and methyl-β-cyclodextrin (MβCD) inhibit degranulation in activated bone marrow-derived mast cells (BMMCs). BMMCs pre-incubated with different concentrations of miltefosine (5–25 µM) (A–C) or MβCD (1–10 mM) (D) were activated and degranulation was measured by β-hexosaminidase release. (A,D) IgE-sensitized cells were activated by high affinity IgE receptor aggregation with Ag. (B) Cells activated with thapsigargin. (C) Cells activated with pervanadate. Values represent mean ± SD (n = 3); **p < 0.01 and ***p < 0.001.